|
1
|
Klein MJ and Siegal GP: Osteosarcoma:
Anatomic and histologic variants. Am J Clin Pathol. 125:555–581.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tian Z, Yang G, Jiang P, Zhang L, Wang J
and Sun S: Long non-coding RNA Sox4 promotes proliferation and
migration by activating Wnt/beta-catenin signaling pathway in
osteosarcoma. Pharmazie. 72:537–542. 2017.PubMed/NCBI
|
|
3
|
Min X, Heng H, Yu HL, Dan M, Jie C, Zeng
Y, Ning H, Liu ZG, Wang ZY and Lin W: Anticancer effects of
10-hydroxycamptothecin induce apoptosis of human osteosarcoma
through activating caspase-3, p53 and cytochrome c pathways. Oncol
Lett. 15:2459–2464. 2018.PubMed/NCBI
|
|
4
|
Lei Z, Duan H, Zhao T, Zhang Y, Li G, Meng
J, Zhang S and Yan W: PARK2 inhibits osteosarcoma cell growth
through the JAK2/STAT3/VEGF signaling pathway. Cell Death Dis.
9:3752018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miao J, Wang W, Wu S, Zang X, Li Y, Wang
J, Zhan R, Gao M, Hu M, Li J and Chen S: MiR-194 suppresses
proliferation and migration and promotes apoptosis of osteosarcoma
cells by targeting CDH2. Cell Physiol Biochem. 45:1966–1974. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu G, Du L, Guo Y, Xing B, Lu J and Wei Y:
Expression and role of microRNA-1271 in the pathogenesis of
osteosarcoma. Exp Ther Med. 15:1934–1940. 2018.PubMed/NCBI
|
|
7
|
Wang H, He H, Meng H, Cui Y and Wang W:
Effects of Grb2-associated binding protein 2-specific siRNA on the
migration and invasion of MG-63 osteosarcoma cells. Oncol Lett.
15:926–930. 2018.PubMed/NCBI
|
|
8
|
Liu DD and Kang Y: Ets2 anchors the
prometastatic function of mutant p53 in osteosarcoma. Genes Dev.
31:1823–1824. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klattenhoff C, Bratu DP, McGinnis-Schultz
N, Koppetsch BS, Cook HA and Theurkauf WE: Drosophila
rasiRNA pathway mutations disrupt embryonic axis specification
through activation of an ATR/Chk2 DNA damage response. Dev Cell.
12:45–55. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Y, Hu B, Wang Q, Ye M, Qiu Q, Zhou Y,
Zeng F, Zhang X, Guo Y and Guo L: Long non-coding RNA HOTTIP
promotes BCL-2 expression and induces chemoresistance in small cell
lung cancer by sponging miR-216a. Cell Death Dis. 9:852018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han Y, Wu N, Jiang M, Chu Y, Wang Z, Liu
H, Cao J, Liu H, Xu B and Xie X: Long non-coding RNA MYOSLID
functions as a competing endogenous RNA to regulate MCL-1
expression by sponging miR-29c-3p in gastric cancer. Cell Prolif.
52:e126782019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan H, Shang G, Cui Y, Liu J, Sun X, Cao
W, Wang Y and Li Y: Long noncoding RNA APTR contributes to
osteosarcoma progression through repression of miR-132-3p and
upregulation of yes-associated protein 1. J Cell Physiol.
234:8998–9007. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv L, Li T, Li X, Xu C, Liu Q, Jiang H, Li
Y, Liu Y, Yan H, Huang Q, et al: The lncRNA Plscr4 controls cardiac
hypertrophy by regulating miR-214. Mol Ther Nucleic Acids.
10:387–397. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Calin GA, Liu CG, Ferracin M, Hyslop T,
Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et
al: Ultraconserved regions encoding ncRNAs are altered in human
leukemias and carcinomas. Cancer Cell. 12:215–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang BF, Cai W and Chen B: LncRNA SNHG12
regulated the proliferation of gastric carcinoma cell BGC-823 by
targeting microRNA-199a/b-5p. Eur Rev Med Pharmacol Sci.
22:1297–1306. 2018.PubMed/NCBI
|
|
18
|
Yuan L, Yuan P, Yuan H, Wang Z, Run Z,
Chen G, Zhao P and Xu B: MiR-542-3p inhibits colorectal cancer cell
proliferation, migration and invasion by targeting OTUB1. Am J
Cancer Res. 7:159–172. 2017.PubMed/NCBI
|
|
19
|
Liu B, Li J, Zheng M, Ge J, Li J and Yu P:
MiR-542-3p exerts tumor suppressive functions in non-small cell
lung cancer cells by upregulating FTSJ2. Life Sci. 188:87–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu
SJ, Xiao CC, Jia CC and Fu BS: Downregulation of miR-542-3p
promotes cancer metastasis through activating TGF-β/Smad signaling
in hepatocellular carcinoma. Onco Targets Ther. 11:1929–1939. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo XF, Wu XJ, Wei X, Wang AG, Wang SH and
Wang JL: LncRNA ADPGK-AS1 regulated cell proliferation, invasion,
migration and apoptosis via targeting miR-542-3p in osteosarcoma.
Eur Rev Med Pharmacol Sci. 23:8751–8760. 2019.PubMed/NCBI
|
|
22
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, He ZC, Liu Q, Zhou K, Shi Y, Yao XH,
Zhang X, Kung HF, Ping YF and Bian XW: Large intergenic Non-coding
RNA-RoR inhibits aerobic glycolysis of glioblastoma cells via Akt
pathway. J Cancer. 9:880–889. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metab. 23:27–47. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu L, Chen X, Sun X, Wang L and Chen S:
The glycolytic switch in tumors: How many players are involved? J
Cancer. 8:3430–3440. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Houddane A, Bultot L, Novellasdemunt L,
Johanns M, Gueuning MA, Vertommen D, Coulie PG, Bartrons R, Hue L
and Rider MH: Role of Akt/PKB and PFKFB isoenzymes in the control
of glycolysis, cell proliferation and protein synthesis in
mitogen-stimulated thymocytes. Cell Signal. 34:23–37. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan S, Wei X, Xu S, Sun H, Wang W, Liu L,
Jiang X, Zhang Y and Che Y:
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3
spatially mediates autophagy through the AMPK signaling pathway.
Oncotarget. 8:80909–80922. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu W, Ye L, Zhang J, Yu P, Wang H, Ye Z
and Tian J: PFK15, a small molecule inhibitor of PFKFB3, induces
cell cycle arrest, apoptosis and inhibits invasion in gastric
cancer. PLoS One. 11:e01637682016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi L, Pan H, Liu Z, Xie J and Han W:
Roles of PFKFB3 in cancer. Signal Transduct Target Ther.
2:170442017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hackett EE, Charles-Messance H, O'Leary
SM, Gleeson LE, Muñoz-Wolf N, Case S, Wedderburn A, Johnston DGW,
Williams MA, Smyth A, et al: Mycobacterium tuberculosis limits host
glycolysis and IL-1β by restriction of PFK-M via MicroRNA-21. Cell
Rep. 30:124–136.e4. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen J, Yu Y, Li H, Hu Q, Chen X, He Y,
Xue C, Ren F, Ren Z, Li J, et al: Long non-coding RNA PVT1 promotes
tumor progression by regulating the miR-143/HK2 axis in gallbladder
cancer. Mol Cancer. 18:332019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song J, Wu X, Liu F, Li M, Sun Y, Wang Y,
Wang C, Zhu K, Jia X, Wang B and Ma X: Long non-coding RNA PVT1
promotes glycolysis and tumor progression by regulating miR-497/HK2
axis in osteosarcoma. Biochem Biophys Res Commun. 490:217–224.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen F, Mo J and Zhang L: Long noncoding
RNA BCAR4 promotes osteosarcoma progression through activating
GLI2-dependent gene transcription. Tumour Biol. 37:13403–13412.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xia WK, Lin QF, Shen D, Liu ZL, Su J and
Mao WD: Clinical implication of long noncoding RNA 91H expression
profile in osteosarcoma patients. Onco Targets Ther. 9:4645–4652.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng H and Min J: Role of long noncoding
RNA HOTAIR in the growth and apoptosis of osteosarcoma cell MG-63.
Biomed Res Int. 2016:57576412016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pillai RS: MicroRNA function: Multiple
mechanisms for a tiny RNA? RNA. 11:1753–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang L, Liu ZM, Rao YW, Cui SQ, Wang H and
Jia XJ: Downregulation of microRNA-586 inhibits proliferation,
invasion and metastasis and promotes apoptosis in human
osteosarcoma U2-OS cell line. Cytogenet Genome Res. 146:268–278.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen L, Wang Q, Wang GD, Wang HS, Huang Y,
Liu XM and Cai XH: MiR-16 inhibits cell proliferation by targeting
IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS
Lett. 587:1366–1372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Zhao C, Yu Z, Chen J, She X, Li P,
Liu C, Zhang Y, Feng J, Fu H, et al: Low expression of miR-381 is a
favorite prognosis factor and enhances the chemosensitivity of
osteosarcoma. Oncotarget. 7:68585–68596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang R, Zhang C, Liu G, Gu R and Wu H:
MicroRNA-126 inhibits proliferation, migration, invasion, and EMT
in osteosarcoma by targeting ZEB1. J Cell Biochem. 118:3765–3774.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu H, Wang H, Liu H and Chen Y: Effect of
miR-143 on the apoptosis of osteosarcoma cells. Int J Clin Exp
Pathol. 8:14241–14246. 2015.PubMed/NCBI
|
|
44
|
Zhong GB, Jiang CQ, Yu XS, Liu ZD, Wang WL
and Xu RD: Long noncoding RNA SNHG8 promotes the proliferation of
osteosarcoma cells by downregulating miR-542-3p. J Biol Regul
Homeost Agents. 34:517–524. 2020.PubMed/NCBI
|
|
45
|
Clementino M, Shi X and Zhang Z: Oxidative
stress and metabolic reprogramming in Cr(VI) carcinogenesis. Curr
Opin Toxicol. 8:20–27. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zancan P, Sola-Penna M, Furtado CM and Da
Silva D: Differential expression of phosphofructokinase-1 isoforms
correlates with the glycolytic efficiency of breast cancer cells.
Mol Genet Metab. 100:372–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ahsan H, Halpern J, Kibriya MG, Pierce BL,
Tong L, Gamazon E, McGuire V, Felberg A, Shi J, Jasmine F, et al: A
genome-wide association study of early-onset breast cancer
identifies PFKM as a novel breast cancer gene and supports a common
genetic spectrum for breast cancer at any age. Cancer Epidemiol
Biomarkers Prev. 23:658–669. 2014. View Article : Google Scholar : PubMed/NCBI
|
